Genesis Healthcare Inc. (NYSE:GEN) received a $1.80 price target from equities research analysts at Bank of America Corp. in a research report issued to clients and investors on Monday. The firm currently has a a “sell” rating on the stock. Bank of America Corp.’s price objective would suggest a potential downside of 33.58% from the company’s current price.

Genesis Healthcare (NYSE:GEN) opened at 2.71 on Monday. The company’s 50-day moving average price is $2.37 and its 200-day moving average price is $2.18. The stock’s market cap is $243.88 million. Genesis Healthcare has a one year low of $1.38 and a one year high of $6.89.

Genesis Healthcare (NYSE:GEN) last issued its quarterly earnings results on Thursday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.01 by $0.27. Genesis Healthcare had a negative return on equity of 5.36% and a negative net margin of 6.25%. The business earned $1.44 billion during the quarter, compared to analysts’ expectations of $1.40 billion. During the same quarter in the previous year, the company posted $0.14 EPS. The company’s quarterly revenue was up 1.3% on a year-over-year basis. Analysts forecast that Genesis Healthcare will post ($1.49) EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC raised its position in shares of Genesis Healthcare by 1.9% in the first quarter. Geode Capital Management LLC now owns 171,157 shares of the company’s stock worth $397,000 after buying an additional 3,206 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Genesis Healthcare by 5.8% in the second quarter. Alliancebernstein L.P. now owns 77,126 shares of the company’s stock worth $137,000 after buying an additional 4,200 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Genesis Healthcare by 0.9% in the second quarter. Vanguard Group Inc. now owns 864,806 shares of the company’s stock worth $1,531,000 after buying an additional 7,773 shares during the last quarter. State Street Corp raised its position in shares of Genesis Healthcare by 2.4% in the first quarter. State Street Corp now owns 404,882 shares of the company’s stock worth $936,000 after buying an additional 9,369 shares during the last quarter. Finally, Panagora Asset Management Inc. raised its position in shares of Genesis Healthcare by 4.4% in the first quarter. Panagora Asset Management Inc. now owns 236,320 shares of the company’s stock worth $548,000 after buying an additional 9,936 shares during the last quarter. Hedge funds and other institutional investors own 8.07% of the company’s stock.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, formerly Skilled Healthcare Group, Inc, is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services, including physician services and other healthcare related services.

5 Day Chart for NYSE:GEN

Receive News & Ratings for Genesis Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.